MR Vaccination in Pregnancy and its Subsequent Complications - Journal of Mazandaran University of Medical Sciences
Volume 17, Number 58 (May 2007)                   J Mazandaran Univ Med Sci 2007, 17(58): 101-108 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abedyan K, Khani S, Shahhosseini Z, Yazdanpanah A. MR Vaccination in Pregnancy and its Subsequent Complications. J Mazandaran Univ Med Sci. 2007; 17 (58) :101-108
URL: http://jmums.mazums.ac.ir/article-1-218-en.html

Abstract:   (7275 Views)
Background and purpose: MR vaccination is prohibited among pregnant women, therefore pregnancy is recommended three months after vaccination. On the other hand, pregnant women acquiring these diseases face unwanted complications. We tried to determine the frequency of congenital disorders in the newborns of the vaccinated pregnant women under 25 years in Mazandaran province.
Materials and Methods: This historical cohort study was done by consent method on 1031 cases throughout Mazandaran province. 406 cases out of the population were vaccinated without prior information about their pregnancy. The data were collected by questionnaires through referring to their healthcare files and telephone contacts just to make sure about their vaccination conditions. The data obtained from these cases along with the data from 493 pregnant women who were not vaccinated during the years 2002-2003 were statistically analyzed.
Results: Pregnancy complications were observed in 58 (6.5%) subjects 24 (41.38%) in the control group and 34 (58.62%) in the case group. The rate of complications in the subjects under the study was as follows: premature delivery in 27 (46.57%) subjects 8 (29.62%) in the control group and 19 (70.38%) in the case group weight under 2500 gram at birth in 19 (32.75%) subjects 12 (63.16%) in the control group and 7 (36.84%) in the case group still birth in 6 (10.34%) subjects 1 (16.67%) in the control group and 5 (83.33%) in the case group abortion in 6 subjects (10.34%) 2 (23.33%) in the control group and 4 in (66.67%) in the case group. Only one person in the control group had intra uterine growth retardation. No significant pregnancy complication difference was observed between the case and the control groups in this study (P>0.05)
Conclusion: Results of this study and the related researches indicate that though MR vaccination during pregnancy is safe, the randomly performed vaccination of pregnant women, should be advised and the followed up for the probable unwanted complications.
Full-Text [PDF 248 kb]   (1268 Downloads)    
Type of Study: Research(Original) |

Add your comments about this article : Your username or email:
Write the security code in the box

© 2015 All Rights Reserved | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb